ibrutinib,rituximab
abbvie,janssen
[' ibru', 'mantle,(-dismantle)', 'ritux', 'lymphoma']
2/ triangle trial (mcl network) new standard in first line mantle cell #lymphoma! adding ibrutinib improves ffs (and presumably os) without benefit of consolidative asct presented by dr martin dreyling #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes